Instituto Maimónides de Investigación Biomédica de Córdoba, University Hospital Reina Sofía, Avda Menéndez Pidal s/n, 14004-Córdoba, Spain.
Circulation. 2011 Sep 27;124(13):1461-8. doi: 10.1161/CIRCULATIONAHA.111.019448. Epub 2011 Aug 29.
Transluminal balloon tearing of the membrane in a thin discrete subaortic stenosis is an alternative to membrane surgical resection. However, the long-term outcome of patients with isolated thin discrete subaortic stenosis treated by transluminal balloon tearing remains unknown.
This 25-year study describes findings from 76 patients with isolated thin discrete subaortic stenosis who underwent percutaneous transluminal balloon tearing of the membrane and were followed up for a mean period of 16±6 years. The age at presentation had a wide range (2-67 years). The mean age at treatment was 19±16 years. Immediately after treatment, the subvalvular gradient decreased from 70±27 to 18±12 mm Hg (P<0.001). No significant postprocedural aortic regurgitation was observed. After a mean follow-up time of 16±6 years, 11 patients (15%) developed restenosis, 3 patients (4%) progressed to muscular obstructive disease, and 1 patient (1.3%) developed a new distant obstructive membrane. Twelve patients (16%) were redilated at a mean of 5±3 years after their first treatment, and 4 patients (5%) underwent surgery at a mean of 3±2 years after their first treatment. Fifty-eight patients (77%) remained alive and free of redilation or surgery at follow-up. Larger annulus diameter and thinner membranes were independent factors associated with better long-term results.
Most patients (77%) with isolated thin discrete subaortic stenosis treated with transluminal balloon tearing of the membrane had sustained relief at subsequent follow-ups without restenosis, the need for surgery, progression to muscular obstructive disease, or an increase in the degree of aortic regurgitation.
经皮腔内主动脉瓣下隔膜切开术治疗局限性薄型隔膜型主动脉瓣下狭窄是一种替代膜切除术的方法。然而,经皮腔内主动脉瓣下隔膜切开术治疗孤立性局限性薄型隔膜型主动脉瓣下狭窄患者的长期预后尚不清楚。
这项长达 25 年的研究描述了 76 例孤立性局限性薄型隔膜型主动脉瓣下狭窄患者的发现,这些患者接受了经皮腔内主动脉瓣下隔膜切开术治疗,并随访了平均 16±6 年。发病时的年龄范围很广(2-67 岁)。治疗时的平均年龄为 19±16 岁。治疗后即刻,瓣下梯度从 70±27mmHg 降至 18±12mmHg(P<0.001)。未观察到明显的主动脉瓣反流。平均随访 16±6 年后,11 例(15%)患者出现再狭窄,3 例(4%)患者进展为肌性梗阻性疾病,1 例(1.3%)患者出现新的远处梗阻性隔膜。12 例(16%)患者在首次治疗后平均 5±3 年再次扩张,4 例(5%)患者在首次治疗后平均 3±2 年接受手术。58 例(77%)患者在随访时存活且无需再次扩张或手术。更大的瓣环直径和更薄的隔膜是与长期结果更好相关的独立因素。
经皮腔内主动脉瓣下隔膜切开术治疗孤立性局限性薄型隔膜型主动脉瓣下狭窄的大多数患者(77%)在随后的随访中持续缓解,无再狭窄、无需手术、进展为肌性梗阻性疾病或主动脉瓣反流程度增加。